In addition, rapamycin significantly decreased the elevated expression of Col1A1, ANP and BNP induced by OSA-Exos treatments and alleviated OSA-Exos-induced cardiomyocyte injury. Here, NPPB is linked to obstructive sleep apnea syndrome.